Your blood can hold a record of past illnesses. That information can reveal how many people have had a certain infection – like 58% of Americans having had COVID-19 by the end of February 2022.
Academic rigor, journalistic flair
Articles on Infection
Displaying 1 - 20 of 71 articles
The two types of COVID-19 tests – antigen and PCR – work in very different ways, which is why one is fast but less accurate and the other is slow and precise.
A COVID-19 vaccine does not cause infertility – but it can protect you from the dangerous complications of contracting the virus.
Researchers are piecing together clues to better understand the puzzling array of symptoms in those who never seem to fully recover from COVID-19.
COVID vaccines don’t contain any live virus to shed. Here’s the science to put the myth of viral shedding after the COVID vaccine to bed.
COVID-19 vaccination produces a more consistent immune response than a past infection. With the delta variant, the difference in protection may be even greater.
Simulations of classrooms and offices can help determine the safest configurations to reduce the spread of COVID-19.
The COVID-19 vaccines are a smash success. But that doesn’t mean they keep every vaccinated person completely free of the coronavirus.
If you’ve already had the coronavirus and recovered, you might be tempted to give the vaccine a pass. A scientist explains why the shot offers the best protection against future infection.
A new study argues for selective border relaxations. But with COVID-19 more prevalent now than at almost any point in the past, the risk would be substantial.
Communication between programmers and local communities can provide good opportunities in the toilet prototyping process from the beginning of the design process.
Resistant bacteria aren’t the only risk posed by overprescribing antibiotics. A more immediate risk is side-effects and reactions, which a new review shows are surprisingly frequent and often severe.
‘Normal’ body temperature has declined in urban, industrialized settings like the US and UK. Anthropologists find the trend extends to Indigenous people in the Bolivian Amazon – but why?
Widely adopted in the US when pandemic precautions kept people home, telehealth faces a challenge as insurance coverage changes, right when its popularity had surged.
Scientists in the UK and Germany discovered a new doorway that the COVID-19 virus uses to infect human cells. This reveals new therapeutic possibilities for blocking the virus.
Over the approaching holidays, people around the world will want to travel to see friends and family. Getting tested for the coronavirus can make this safer, but testing alone is not a perfect answer.
Patients suffering from severe COVID-19 may be experiencing a rogue antibody response similar to that seen in autoimmune diseases. The findings offer new approaches for COVID-19 therapy.
The 17th-century plague of Italy has lessons for today: Back then, too, people broke public health laws, but there were clergymen who intervened.
Our video shows aerosol emissions from singing a simple scale. No wonder singing in a choir can be risky.
Some 70-80% of health-care workers testing positive to COVID-19 in Victoria’s second wave were infected at work, compared with 22% in the first wave.
Top contributors
-
Instructor of Human Immunology, Emory University
-
Clinical Assistant Professor of Immunology, University of South Carolina
-
Adjunct Associate Professor, Menzies Centre for Health Policy, University of Sydney
-
Prof. Institute for Molecular Bioscience, The University of Queensland
-
Professor, School of Mechanical and Manufacturing Engineering, UNSW Sydney
-
Professor and Director of Doherty Epidemiology, The University of Melbourne
-
Specialist General Practitioner, and Conjoint Senior Lecturer, UNSW Sydney
-
Professor in Evolutionary Biology (jointly appointed with South Australian Museum), Flinders University
-
Senior Lecturer, School of Computing and Information Systems, University of Melbourne; Senior Research Fellow, Doherty Institute for Infection and Immunity, The University of Melbourne
-
Adjunct Senior Research Fellow in Early Childhood Development, The University of Western Australia
-
IMB Fellow, The University of Queensland
-
Emeritus Professor, School of Public Health, Queensland University of Technology
-
Professor at ANU Medical School; Senior Staff Specialist Infectious Diseases; General Physician, Australian National University
-
NHMRC Research Fellow, Telethon Kids Institute, The University of Western Australia
-
Professor of Global Biosecurity, NHMRC Principal Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
